Overall, we provide proof of concept that CAR-T can selectively, systemically, and durably deplete DC1 to modulate autoimmunity and DC1-targeted CAR-Tregs can suppress passive Th1-induced EAE. The gene discussed is ZDHHC4; the disease is Autoimmunity.